- Home
- MBWM vs MGTX Comparison
MBWM vs MGTX Comparison
Compare MBWM & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBWM | MGTX |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 791.9M | 665.7M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | MBWM | MGTX |
|---|---|---|
| Price | $48.46 | $7.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $52.88 | $23.83 |
| AVG Volume (30 Days) | 98.2K | ★ 515.2K |
| Earning Date | 01-20-2026 | 11-13-2025 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 6.26 | N/A |
| EPS | ★ 5.27 | N/A |
| Revenue | ★ $233,714,000.00 | $27,417,000.00 |
| Revenue This Year | $10.44 | N/A |
| Revenue Next Year | $11.11 | $619.95 |
| P/E Ratio | $9.18 | ★ N/A |
| Revenue Growth | 5.19 | ★ 96.83 |
| 52 Week Low | $37.76 | $4.55 |
| 52 Week High | $51.89 | $9.73 |
Technical Indicators
Market Signals| Indicator | MBWM | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 42.91 |
| Support Level | $48.07 | $7.77 |
| Resistance Level | $49.44 | $8.40 |
| Average True Range (ATR) | 1.12 | 0.52 |
| MACD | -0.20 | -0.07 |
| Stochastic Oscillator | 39.19 | 6.52 |
Price Performance
Historical ComparisonAbout MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.